Infection with hepatitis G virus among recipients of plasma products

Lancet

Volumn 348, Issue 9038, 1996, Pages 1352-1355

  Jarvis, L M ^a   Davidson, F ^b   Hanley, J P ^a   Yap, P L ^b   Ludlam, C A ^a   Simmonds, P ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Edinburgh S E Scotland Blood T   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9 CONCENTRATE; COMPLEMENTARY DNA; IMMUNOGLOBULIN; VIRUS RNA;

ARTICLE; BLOOD DONOR; CONTROLLED STUDY; DRUG CONTAMINATION; FEMALE; FLAVIVIRUS; HEMOPHILIA; HEPATITIS; HEPATITIS G VIRUS; HUMAN; HYPOGAMMAGLOBULINEMIA; MAJOR CLINICAL STUDY; MALE; PERSISTENT INFECTION; PLASMA; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; VIRUS INACTIVATION; VIRUS INFECTIVITY; VIRUS TRANSMISSION;

EID: 0030590748     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)04041-X     Document Type: Article

References (18)

1. Leary TP, Muerhoff AS, Simons JN, et al. Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E hepatitis. J Med Virol. 48:1996;60-67.
2. Linnen J, Wages J, ZhangKeck ZY, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 271:1996;505-508.
3. Muerhoff AS, Leary TP, Simons JN, et al. Genomic organization of GB viruses A and B: two new members of the flaviviridae associated with GB agent hepatitis. J Virol. 69:1995;5621-5630.
4. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet. 346:1995;1131-1132.
5. Kao JH, Chen PJ, Chen DS. GBV-C in the aetiology of fulminant hepatitis. Lancet. 347:1996;120.
6. Simons JN, Leary TP, Dawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med. 1:1995;564-569.
7. Jarvis LM, Watson HG, McOmish F, Peutherer JF, Ludlam CA, Simmonds P. Frequent reinfection and reactivation of hepatitis C virus genotypes in multitransfused hemophiliacs. J Infect Dis. 170:1994;1018-1022.
8. Davidson F, Simmonds P, Ferguson JC, et al. Survey of major genotypes and subtypes of hepatitis C virus using restriction fragment length polymorphism of sequences amplified from the 5′ non-coding region. J Gen Virol. 76:1995;1197-1204.
9. Simmonds P, Zhang LQ, Watson HG, et al. Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users. Lancet. 336:1990;1469-1472.
10. Crawford RJ, Gillon J, Yap PL, et al. Prevalence and epidemiological characteristics of hepatitis C in Scottish blood donors. Transfus Med. 4:1994;121-124.
11. Fletcher ML, Trowell JM, Craske J, Pavier K, Rizza CR. Non-A, non-B hepatitis after transfusion of factor VIII in infrequently treated patients. BMJ. 287:1983;1754-1757.
12. Tedder RS, Briggs M, Ring C, et al. Hepatitis C antibody profile and viraemia prevalence in adults with severe haemophilia. Br J Haematol. 79:1991;512-515.
13. Watson HG, Ludlam CA, Rebus S, Zang LQ, Peutherer JF, Simmonds P. Use of several second generation assays to determine the true prevalence of hepatitis C infection in haemophiliacs treated with non-virus inactivated factor VIII and IX concentrates. Br J Haematol. 80:1992;514-518.
14. Follett EAC, Dow BC, McOmish F, et al. HCV confirmatory testing of blood donors. Lancet. 339:1992;928.
15. Weiner AJ, Geysen HM, Christopherson C, et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci USA. 89:1992;3468-3472.
16. Choo QL, Richman KH, Han JH, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA. 88:1991;2451-2455.
17. Feucht HH, Zollner B, Polywka S, Laufs R. Vertical transmission of hepatitis G. Lancet. 347:1996;615-616.
18. Moaven LD, Tonnakoon PS, Bowden DS, Locarnini SA. Mother-to-baby transmission of hepatitis G virus. Med J Aust. 165:1996;84-85.